Commentary & Perspectives

What Will Redefine Pathology in 2026?

Industry leaders outline how computational modeling and large-scale sequencing will reshape discovery, diagnostics, and clinical development in 2026 and beyond

Share

In 2026, advancements in pathology and laboratory medicine promise to reshape the field. Key predictions include the rise of creative AI in R&D, enhanced long-read sequencing for genetic disorders like Huntington's disease, and increased investment in population-specific genomics. The integration of AI for disease target identification and biological modeling will streamline research processes. Digital twins are expected to gain traction in clinical trials, supported by evolving regulatory frameworks. Unified AI in R&D will replace siloed systems, ultimately improving diagnostic accuracy and efficiency.

Original Source(s)

What Will Redefine Pathology in 2026?

Industry leaders outline how computational modeling and large-scale sequencing will reshape discovery, diagnostics, and clinical development in 2026 and beyond

  • by Jessica Allerton

  • January 14, 2026

  • 7 min

Related Content

Polymerase Mutations Shape Distinct Cancer Risks

Germline mutations in POLE and POLD1 are linked to variable cancer risks, with findings highlighting mutation-specific differences that refine tumor predisposition assessment.

Cancer Genomics Pioneer Honored by AMP

In her keynote lecture, Elaine R. Mardis, PhD, discussed advances in pediatric precision medicine and encouraged the expansion of data-sharing initiatives.

Delving into the Dark Code

Genome exploration tool Orion digs into non-coding regions for disease-causing mutations